Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Antibodies to vascular endothelial growth factor in non-small cell lung cancerHeather WakeleeCurrent Opinion in Molecular Therapeutics|August 3, 2010
AMG-386, a selective angiopoietin-1/-2-neutralizing peptibody for the potential treatment of cancerJoel Neal, Heather WakeleeCurrent Treatment Options in Oncology|July 20, 2007
Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitorsElwyn Cabebe, Heather WakeleeDrugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Sunitinib: a newly approved small-molecule inhibitor of angiogenesisElwyn Cabebe, Heather WakeleeExpert Opinion on Therapeutic Targets|March 24, 2012
Targeting VEGF in lung cancerMillie Das, Heather WakeleeTranslational Lung Cancer Research|March 26, 2015
Angiogenesis and lung cancer: ramucirumab prolongs survival in 2(nd)-line metastatic NSCLCMillie Das, Heather WakeleeSeminars in Thoracic and Cardiovascular Surgery|November 29, 2008
Adjuvant chemotherapy for resected non-small cell lung cancerHeather Wakelee, Laveena ChhatwaniCurrent Treatment Options in Oncology|December 14, 2005
Second- and third-line treatments in non-small cell lung cancerAtul Kumar, Heather WakeleeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2009
Antiangiogenic agents and vascular disrupting agents for the treatment of lung cancer: a reviewChristelle Clément-Duchêne, Heather WakeleeDrugs of Today (Barcelona, Spain : 1998)|January 13, 2009
Pemetrexed disodium for the treatment of NSCLC: an updateJerry Y Hsu, Heather WakeleePageof 10